Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/29/1990 | EP0384122A2 Mutants of human antithrombin III |
08/29/1990 | EP0383919A1 Staurosporin derivatives |
08/29/1990 | EP0383837A1 Alveolar surfactant proteins |
08/29/1990 | EP0383803A1 Oligonucleotide-polyamide conjugates |
08/29/1990 | EP0383799A1 Adheson variants |
08/29/1990 | EP0383764A1 Bovine granulocyte-macrophage colony stimulating factor. |
08/29/1990 | EP0216832B1 Novel insulin derivatives and pharmaceutical preparations containing these derivatives |
08/29/1990 | CN1044955A Enterically transmitted non-a/non-b hepatitis viral agent |
08/29/1990 | CA2028121A1 Human monoclonal antibodies to human immunodeficiency virus |
08/28/1990 | US4952675 Method for purifying antihemophilic factor |
08/28/1990 | US4952562 Anti-thrombotic peptides and pseudopeptides |
08/28/1990 | US4952561 Cardiac atrial peptides |
08/28/1990 | US4952493 Peptide substrates for detecting virus-specified protease activity |
08/28/1990 | US4952409 Superoxide dismutase-containin liposome applied to organ to be transplanted to warm-blooded animals |
08/28/1990 | US4952406 Released proteins control changes in ph and concentration of active materials |
08/28/1990 | US4952404 Promotion of healing of meniscal tissue |
08/28/1990 | US4952403 Implants for the promotion of healing of meniscal tissue |
08/28/1990 | US4952396 Or salts or hydrolyzates; oral administration |
08/28/1990 | CA1273450A1 Nootropic imidazolidinomes |
08/28/1990 | CA1273304A1 Compositions and process for protecting lymphocytes t againtst the etiologic agent of lymphadenopathies and aquired immunodeficiency syndrome |
08/28/1990 | CA1273294A1 Production of a-a cross-linked hemoglobins in high yield |
08/27/1990 | CA2010777A1 Peptide lactone and derivatives thereof, a process for the preparation thereof and means for carrying out the process |
08/27/1990 | CA2002307A1 Sequential heat treatment of blood-clotting factor products |
08/25/1990 | WO1990009798A1 Immobilized cytokines |
08/25/1990 | CA2047730A1 Immobilized cytokines |
08/24/1990 | WO1990010017A1 Periodontal and bone regeneration factor, materials and methods |
08/24/1990 | WO1990009781A1 Therapeutic aerosol formulations |
08/24/1990 | CA2050905A1 Therapeutic aerosol formulations |
08/24/1990 | CA2027583A1 Periodontal and bone regeneration factor, materials and methods |
08/24/1990 | CA2010328A1 Milled protein |
08/23/1990 | WO1990010066A1 New protease inhibitor and production thereof |
08/23/1990 | WO1990009444A1 A method for producing pertussis toxin subunits |
08/23/1990 | WO1990009442A1 Antiproliferation factor |
08/23/1990 | WO1990009391A1 Nucleic acid encoding sodium channel protein |
08/23/1990 | WO1990009197A1 Novel monoclonal antibody to novel antigen associated with human tumors |
08/23/1990 | WO1990009194A1 Use of il-7 in providing medications for stimulation of platelet production |
08/23/1990 | WO1990009192A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
08/23/1990 | WO1990009191A1 Agent for inhibiting symmetrical proteins, in particular enzymes |
08/23/1990 | WO1990009190A1 In ovo administration of growth factors alters physiological development and response of poultry |
08/23/1990 | WO1990009189A1 Treatment of pulmonary dysfunction and ventilator dependency with growth hormone |
08/23/1990 | WO1990009188A1 In ovo administration of growth factors alters physiological development and response of poultry |
08/23/1990 | WO1990009187A1 Eye drops for healing wound of corneal epithelium |
08/23/1990 | WO1990009183A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
08/23/1990 | WO1990009179A1 Treatment of tibial dyschondroplasia |
08/23/1990 | WO1990009172A1 Phosphorus containing renin inhibitors |
08/23/1990 | WO1990009162A2 Anaphylatoxin-receptor ligands |
08/23/1990 | DE4005190A1 Neue cyclosporinhaltige galenische formen New cyclosporin galenic form |
08/23/1990 | DE3904962A1 Foods, dietetic foods, food additives and medicaments based on yeast and distiller's spent grains |
08/23/1990 | CA2025537A1 Protease inhibitor and process for producing it |
08/23/1990 | CA2010660A1 Osteogenic growth polypeptides identified from regenerating bone marrow |
08/22/1990 | EP0383645A1 Process to prepare a very pure antihaemophilic factor. |
08/22/1990 | EP0383620A2 Process for making genes encoding random polymers of amino acids |
08/22/1990 | EP0383599A2 Protein anti-cancer agent |
08/22/1990 | EP0383569A2 Storage of materials |
08/22/1990 | EP0383472A2 Insulin analogs |
08/22/1990 | EP0383453A1 A reg protein |
08/22/1990 | EP0383417A1 Vampire bat salivary Plasminogen activator vPA-alpha 1 |
08/22/1990 | EP0383363A2 Use of wound healing agents |
08/22/1990 | EP0383258A2 Pharmaceutical compositions for reducing pre and post-ischemic myocardial arrhythmias and fibrillation |
08/22/1990 | EP0383234A2 Pasteurised purified von Willebrand factor concentrate, and method for its preparation |
08/22/1990 | EP0383205A1 Somatotropin binding protein |
08/22/1990 | EP0383190A2 Ribonucleotide reductase inhibitors |
08/22/1990 | EP0383129A2 Pancreatic islet cell antigens obtained by molecular cloning |
08/22/1990 | EP0383090A1 Human monoclonal antibody to pseudomonas Aeruginosa, and its production and use |
08/22/1990 | EP0382875A1 Dispersant for biologically active peptide |
08/22/1990 | EP0382842A1 Nootropic |
08/22/1990 | EP0382841A1 Wound healing. |
08/22/1990 | EP0382814A1 Nisin compositions for use as enhanced, broad range bactericides. |
08/22/1990 | EP0382783A1 Antibodies to natural killer cell and non-specific cytotoxic cell receptor |
08/22/1990 | EP0382772A1 Reduction of low density lipoproteins in biological fluids. |
08/22/1990 | CN1044820A Insulin analogs |
08/22/1990 | CN1044807A Composition for denatured denaturation or protection agent for nerve cell and process for preparing benzene derivatives used for composition |
08/22/1990 | CN1044761A Prolonged release of biologically active polyepeptides |
08/21/1990 | US4950739 Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels |
08/21/1990 | US4950655 Composition for treating and preventing diarrhoea in humans and animals and a method of preparing same |
08/21/1990 | US4950652 Aids and aids-related complex |
08/21/1990 | US4950651 Nitroso-N-(β-chloro ethyl)-carbamoyl peptides |
08/21/1990 | US4950650 Hypotensive agents |
08/21/1990 | US4950646 DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides |
08/21/1990 | US4950645 Antitumor agents; nontoxic; activates human monocytes |
08/21/1990 | US4950589 Genus-specific listeria antigen identified by monoclonal antibodies |
08/21/1990 | US4950483 Implantation, fibrils are not cross-linked |
08/21/1990 | US4950465 Pharmaceutical composition for relieving side effects of platinum-containing drugs |
08/21/1990 | CA1273150A1 Reduced peptides which inhibit gastric secretion, process for their preparation and pharmaceutical compositions in which they are present |
08/18/1990 | WO1990010081A1 Soluble analogs of thrombomodulin |
08/18/1990 | WO1990009385A1 Lipid excipient for nasal delivery and topical application |
08/18/1990 | CA2046906A1 Soluble analogs of thrombomodulin |
08/18/1990 | CA2045469A1 Lipid excipient for nasal delivery and topical application |
08/17/1990 | CA2010253A1 Monoclonal antibody to novel antigen associated with human tumors |
08/17/1990 | CA2010118A1 Somatotropin binding protein |
08/17/1990 | CA2009996A1 Process for making genes encoding random polymers of amino acids |
08/16/1990 | EP0382538A2 A process for the preparation of cysteine-rich polypeptides, including echistatin |
08/16/1990 | EP0382451A2 Viper venom Polypeptides and variants |
08/16/1990 | EP0382411A2 Delivery of cytotoxic agents |
08/16/1990 | EP0382381A1 Treatment of leukocyte dysfunction with GM-CSF |
08/16/1990 | EP0382251A2 New adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use |
08/16/1990 | EP0382213A2 Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent |
08/16/1990 | EP0382180A2 Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it |
08/16/1990 | EP0382174A1 Derivative of a tissue plasminogen activator |
08/16/1990 | EP0382031A2 Monoclonal antibodies in immune serum globulin |